Amgen
AMGN
#99
Rank
C$245.81 B
Marketcap
C$456.49
Share price
-3.02%
Change (1 day)
19.51%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

Operating Margin for Amgen (AMGN)

Operating Margin as of December 2025 (TTM): 22.91%

According to Amgen's latest financial reports and stock price the company's current Operating Margin is 22.91%. At the end of 2024 the company had an Operating Margin of 13.79%.

Operating Margin history for Amgen from 2001 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
202413.79%-50.51%
202327.86%-0.15%
202227.91%8.19%
202125.79%-19.37%
202031.99%-18.22%
201939.11%-2.69%
201840.19%-4.3%
201742.00%5.39%
201639.85%8.21%
201536.83%32.3%
201427.84%-1.26%
201328.19%-2.83%
201229.01%8.93%
201126.63%-24.6%
201035.32%-0.62%
200935.54%6.33%
200833.43%24.65%
200726.82%-4.82%
200628.17%-28.06%
200539.16%21.7%
200432.18%-15.25%
200337.97%-406.17%
2002-12.40%-129.54%
200141.99%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Pfizer
PFE
12.60%-45.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
16.72%-27.02%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
22.01%-3.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
33.98% 48.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
18.91%-17.46%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
2.78%-87.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
18.78%-18.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
-26.96%-217.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
37.87% 65.30%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.